{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,19]],"date-time":"2026-11-19T18:20:37Z","timestamp":1795112437235,"version":"4.10.3"},"reference-count":28,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,10,3]],"date-time":"2021-10-03T00:00:00Z","timestamp":1633219200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/501100004663","name":"Ministry of Science and Technology, Taiwan","doi-asserted-by":"publisher","award":["107\u20102320\u2010B\u2010006\u2010070\u2010MY3"],"award-info":[{"award-number":["107\u20102320\u2010B\u2010006\u2010070\u2010MY3"]}],"id":[{"id":"10.13039\/501100004663","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ascpt.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Clin Pharma and Therapeutics"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:p>This is a retrospective cohort study by analyzing a multi\u2010institutional electronic medical records database covering 1.3\u00a0million individuals (6% of Taiwan\u2019s population) to compare the risk of heart failure (HF) in patients with rheumatoid arthritis (RA) treated with tumor necrosis factor\u2010\u03b1 (TNF\u2010\u03b1) inhibitors or conventional synthetic disease\u2010modifying anti\u2010rheumatic drugs (csDMARDs). We included patients with RA aged 20\u00a0years and older who had treatment failure with at least 2 different csDMARD regimens and newly switched to another csDMARD regimen or TNFis from 2009 to 2019. We followed patients from initiation of the new therapies to the occurrence of hospitalization for heart failure (hHF), death, to the last clinical visit or December 31, 2020. We performed multivariable Cox proportional hazard models to compare TNF\u2010\u03b1 inhibitors and csDMARD groups for the risk of hHF, with adjustment for patients\u2019 characteristics. A total of 1,278 TNF\u2010\u03b1 inhibitors and 1,932 csDMARDs treated patients were identified, with 78% being women and having an average age of 55 (SD 13.28) years. The incidence rates of hHF for the TNF\u2010\u03b1 inhibitors and csDMARD groups were 3.66 and 4.72 per 1,000 person\u2010years, respectively (adjusted hazard ratio (aHR) 0.59; 95% confidence interval (CI) 0.35\u20130.97), and the results remained consistent in patients both with an HF history (aHR 0.66; 95% CI 0.03\u201314.46) and without (aHR 0.49; 95% CI, 0.27\u20130.89). The findings suggest that those who switched to TNF\u2010\u03b1 inhibitors had a reduced risk of hHF, compared with those who switched to another csDMARD regimen.<\/jats:p>","DOI":"10.1002\/cpt.2415","type":"journal-article","created":{"date-parts":[[2021,9,8]],"date-time":"2021-09-08T20:11:25Z","timestamp":1631131885000},"page":"1595-1603","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Risk of Heart Failure in Rheumatoid Arthritis Patients Treated with Tumor Necrosis Factor\u2010\u03b1 Inhibitors"],"prefix":"10.1111","volume":"110","author":[{"given":"Hung\u2010Kai","family":"Chen","sequence":"first","affiliation":[{"name":"School of Pharmacy Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine National Cheng Kung University Tainan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shih\u2010Chieh","family":"Shao","sequence":"additional","affiliation":[{"name":"School of Pharmacy Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine National Cheng Kung University Tainan Taiwan"},{"name":"Department of Pharmacy Keelung Chang Gung Memorial Hospital Keelung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng\u2010Yu","family":"Weng","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology, and Rheumatology Department of Internal Medicine College of Medicine National Cheng Kung University Hospital National Cheng Kung University Tainan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swu\u2010Jane","family":"Lin","sequence":"additional","affiliation":[{"name":"Department of Pharmacy Systems, Outcomes and Policy College of Pharmacy University of Illinois at Chicago Chicago Illinois USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming\u2010Jui","family":"Hung","sequence":"additional","affiliation":[{"name":"College of Medicine Chang Gung University Taoyuan Taiwan"},{"name":"Section of Cardiology Department of Internal Medicine Keelung Chang Gung Memorial Hospital Keelung Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuk\u2010Ying","family":"Chan","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutical Materials Management Chang Gung Medical Foundation Taoyuan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5852-7652","authenticated-orcid":false,"given":"Edward Chia\u2010Cheng","family":"Lai","sequence":"additional","affiliation":[{"name":"School of Pharmacy Institute of Clinical Pharmacy and Pharmaceutical Sciences College of Medicine National Cheng Kung University Tainan Taiwan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2021,10,3]]},"reference":[{"key":"e_1_2_12_1_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2011-200726"},{"key":"e_1_2_12_2_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.tcm.2016.07.006"},{"key":"e_1_2_12_3_1","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.k1036"},{"key":"e_1_2_12_4_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.20855"},{"key":"e_1_2_12_5_1","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.117.007227"},{"key":"e_1_2_12_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2016.12.033"},{"key":"e_1_2_12_7_1","doi-asserted-by":"publisher","DOI":"10.1007\/s10741-010-9180-8"},{"key":"e_1_2_12_8_1","doi-asserted-by":"publisher","DOI":"10.3390\/ijms19061739"},{"key":"e_1_2_12_9_1","doi-asserted-by":"publisher","DOI":"10.1002\/acr.22783"},{"key":"e_1_2_12_10_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2019-216655"},{"key":"e_1_2_12_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.amjmed.2003.09.039"},{"key":"e_1_2_12_12_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/keh610"},{"key":"e_1_2_12_13_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00296-006-0215-3"},{"key":"e_1_2_12_14_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/kem212"},{"key":"e_1_2_12_15_1","doi-asserted-by":"publisher","DOI":"10.1002\/art.23281"},{"key":"e_1_2_12_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ahj.2008.02.025"},{"key":"e_1_2_12_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.trsl.2010.09.005"},{"key":"e_1_2_12_18_1","doi-asserted-by":"publisher","DOI":"10.1093\/rheumatology\/ket333"},{"key":"e_1_2_12_19_1","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2012-202136"},{"key":"e_1_2_12_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/pds.4713"},{"key":"e_1_2_12_21_1","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0170408"},{"key":"e_1_2_12_22_1","article-title":"Different implications of heart failure, ischemic stroke, and mortality between nonvalvular atrial fibrillation and atrial flutter\u2010a view from a National Cohort Study","volume":"6","author":"Lin Y.S.","year":"2017","journal-title":"J. Am. Heart Assoc."},{"key":"e_1_2_12_23_1","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2018.0246"},{"key":"e_1_2_12_24_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12933-019-0919-9"},{"key":"e_1_2_12_25_1","doi-asserted-by":"publisher","DOI":"10.1093\/ndt\/gfu325"},{"key":"e_1_2_12_26_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCOUTCOMES.113.000359"},{"key":"e_1_2_12_27_1","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.113.302024"},{"key":"e_1_2_12_28_1","doi-asserted-by":"publisher","DOI":"10.1002\/cpt.2127"}],"container-title":["Clinical Pharmacology &amp; Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2415","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1002\/cpt.2415","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/cpt.2415","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,7]],"date-time":"2023-11-07T13:38:48Z","timestamp":1699364328000},"score":1,"resource":{"primary":{"URL":"https:\/\/ascpt.onlinelibrary.wiley.com\/doi\/10.1002\/cpt.2415"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,3]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1002\/cpt.2415"],"URL":"https:\/\/doi.org\/10.1002\/cpt.2415","archive":["Portico"],"relation":{},"ISSN":["0009-9236","1532-6535"],"issn-type":[{"value":"0009-9236","type":"print"},{"value":"1532-6535","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,3]]},"assertion":[{"value":"2021-05-30","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-08-22","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-10-03","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}